Synthetic Biologics (SYN) News Today

SourceHeadline logoGenScript Singapore's Open Day Reveals Pioneering AI Capabilities in Recombinant Protein Production and Drug Discovery - April 24 at 12:07 AM logoActive Pharmaceutical Ingredient Market Trends Signal Growth Towards USD 446.6 Billion by 2032 With CAGR AT 6.4% - April 23 at 2:06 PM logoTheriva Biologics Announces Positive Data From Phase 1 Trial Of VCN-01 In Intraocular Retinoblastoma - April 23 at 2:06 PM logoElon Musk rejects Tucker Carlson’s viral alien conspiracy theory - April 22 at 5:48 PM logoAziyo Biologics Poised for Growth: Buy Rating Affirmed Amidst Anticipated FDA Clearance and Strong Financial Outlook - April 19 at 3:26 PM logoX-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA) - April 17 at 9:52 AM logoMustGrow Biologics to Present at the Planet MicroCap Showcase - April 17 at 9:52 AM logo31 Netizens Share What They Consider To Be Next Big Changes In The Culture Of The Internet - April 10 at 8:07 PM logoAffini-T Therapeutics Presents Preclinical Data from its Oncogenic Driver Programs Targeting KRAS G12D and p53 R175H at the American Association for Cancer Research (AACR ... - April 7 at 11:51 PM logoSix Arizona Startups Driving Biosciences Forward in 2024 - April 3 at 4:13 PM logoRetinitis Pigmentosa Market to Grow Rapidly at a CAGR of 16.8% by 2034 | DelveInsight - April 2 at 6:24 PM logoBCC Research Reveals Top Ten Suppliers of Synthetic Biology Technology in 2024 - April 2 at 1:59 PM logoPharmaceutical Membrane Filtration Market is Expected to Reach $19.6 billion | MarketsandMarkets™ - March 30 at 2:10 AM logoBuy Recommendation for Theriva Biologics Backed by Promising Oncolytic Adenovirus Platform and Clinical Trial Advancements - March 27 at 7:41 PM logoWhy Is Your Pubic Hair Itchy—and How Can You Treat It? - March 26 at 12:36 PM logoUpdated recommendations for psoriatic arthritis - March 25 at 4:34 PM logoHumacyte, Inc. (NASDAQ:HUMA) Q4 2023 Earnings Call Transcript - March 23 at 11:04 AM logo6 Analysts Assess Absci: What You Need To Know - March 22 at 5:56 PM logoSamsung Life Science Fund invests in Massachusetts-based BrickBio - March 19 at 9:45 AM logoWhat Is Pustular Psoriasis? - March 18 at 10:38 AM logoGRO Biosciences Expands Executive Team with Appointment of Biopharma Veteran Tracey Lodie, PhD as Chief Development Officer - March 18 at 8:43 AM logoSamsung Invests in BrickBio to Develop Advanced Molecules and Therapies Using Protein Engineering Technology for Antibody-Drug Conjugates (ADC) - March 18 at 8:43 AM logoBlinken Calls for Closer Global Cooperation on Tackling Synthetic Drugs - March 17 at 10:42 PM logoAgricultural Biologicals Market Analysis Report 2024-2030 - Market to Reach USD 12.62 Billion by 2030, Asia-Pacific to Exhibit Rapid Growth - March 14 at 2:53 PM logoAfter 50 years, Tommy John surgery is evolving to increase success and sometimes speed return - March 14 at 8:33 AM logoGenScript Biotech Corporation: GenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30% - March 12 at 10:37 AM logoPearl Bio Inks Collaboration with Merck to Discover Novel Engineered Biologics - March 12 at 8:34 AM logoOrthofix Medical Inc. (NASDAQ:OFIX) Q4 2023 Earnings Call Transcript - March 7 at 10:28 AM logoSurGenTec® Receives FDA Clearance for OsteoFlo® HydroPutty™, a Hydrophilic Synthetic Bone Graft - March 7 at 10:28 AM logoThe Analyst Landscape: 4 Takes On Absci - March 6 at 6:09 PM logo3 AI-Driven Drug Stocks to Buy Before They Breakout - February 29 at 6:11 PM logoHow to manage eczema – according to a dermatologist - February 29 at 1:11 PM logoBayer, AgStart launch competition to find ag and food startups that need free lab space - February 29 at 1:11 PM Announced as Inaugural Partner of Ginkgo Bioworks’ New Technology Network - February 28 at 8:14 AM logoShort sales on the TSX: What bearish investors are betting against - February 26 at 12:13 PM logoTwist Bioscience (TWST) Price Target Increased by 19.85% to 41.57 - February 25 at 6:10 AM logoYour Guide To Axial Spondyloarthritis Treatments - February 23 at 9:35 AM logoNurExone Biologic Inc: NurExone Launches Licensing Efforts for ExoTherapy Platform - February 15 at 9:35 AM logoGroup hits lone Democrat over drug pricing bill - February 14 at 12:10 AM logoNebraska lawmakers to hear bill that asks farmers to use biologic products rather than synthetic nitrogen - February 14 at 12:10 AM logoNebraska senator trying to pass bill that would provide farmers with incentives to use biologic products rather than synthetic nitrogen - February 14 at 12:10 AM logoHumacyte (HUMA) Up on HAV BLA Priority Tag for Vascular Trauma - February 12 at 1:51 PM logoHumacyte Receives FDA Priority Review for Vascular Repair Solution - February 10 at 8:12 AM logoWhy Is Clinical-Stage Biotechnology Platform Company Humacyte Stock Gaining Friday? - February 9 at 2:33 PM logoHumacyte gains on FDA priority review for bioengineered blood vessel - February 9 at 9:32 AM logoErectile Dysfunction Drugs Like Viagra May Reduce Alzheimer’s Risk, Study Finds - February 8 at 2:15 PM logoBiosimilar insulin: Startup takes new approach to make insulin affordable - February 4 at 5:07 AM logoRise Therapeutics begins rheumatoid arthritis therapy trial - January 30 at 6:00 PM logoFirst Patient Enrolled in Rise Therapeutics' Rheumatoid Arthritis Clinical Trial - January 29 at 10:38 AM logoMerck inks $220M deal for cancer drug discovery - January 23 at 3:03 PM
Get Synthetic Biologics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SYN and its competitors with MarketBeat's FREE daily newsletter.

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

SYN Media Mentions By Week

SYN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

News Sentiment



News Sentiment

SYN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SYN Articles
This Week



SYN Articles
Average Week

Get Synthetic Biologics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SYN and its competitors with MarketBeat's FREE daily newsletter.

Related Companies and Tools

This page (NYSEAMERICAN:SYN) was last updated on 4/24/2024 by Staff

From Our Partners